Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group (Q30788900)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group |
scientific article |
Statements
1 reference
Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation. Nagoya BMT Group (English)
1 reference
Mizuta S
1 reference
Ito Y
1 reference
Kohno A
1 reference
Kiyoi H
1 reference
Miyamura K
1 reference
Tanimoto M
1 reference
Takamatsu J
1 reference
Naoe T
1 reference
Morishima Y
1 reference
Ueda R
1 reference
Saito H
1 reference
1 October 1999
1 reference
1 reference
Identifiers
1 reference